Cholesterol supplementation in Smith-Lemli-Opitz syndrome
β Scribed by Abuelo, Dianne N.
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 2 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0148-7299
- DOI
- 10.1002/(sici)1096-8628(19980724)78:4<378::aid-ajmg14>3.0.co;2-f
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We describe three unrelated patients with adrenal insufficiency and RSH or Smith-Lemli-Opitz syndrome (SLOS), a disorder due to deficient synthesis of cholesterol. These patients presented with hyponatremia, hyperkalemia, and decreased aldosterone-to-renin ratio, which is a sensitive measure of the
## To the Editor: The incidence of Smith-Lemli-Opitz syndrome (SLOS, McKusick 270 400) has been estimated to be approximately 1 in 50,000 to 1 in 20,000 births in North Americans [Kelley, 1997;Lowry and Yong, 1980]. However, the incidence greater than 1 in 10,000 in a completely ascertained newborn
Smith-Lemli-Opitz (SLO or RSH) syndrome is characterized by multiple congenital anomalies, mental retardation, and defective growth; it results from an inherited defect in the biosynthesis of cholesterol. Patients have elevated plasma concentrations of 7-dehydrocholesterol, the immediate biosyntheti
We describe the antenatal ultrasound findings of growth retardation, oligohydramnios, mesomelic limb shortness, and cardiac, renal, and hand defects in a fetus who was postnatally diagnosed as having RSH ("Smith-Lemli-Opitz") syndrome. An unusual finding was ectrodactyly of both hands.